The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and postal research

Bennett, Mike; Smith, Blair H.; Torrance, Nicola; Potter, Jean

doi:10.1016/j.jpain.2004.11.007

Cited by 532 publications

(463 citation statements)

References 19 publications

Supporting

Mentioning

436

Contrasting

Unclassified

Order By: Relevance

“…Such characteristics suggest mechanisms that are shared with neuropathic pain 2. The painDETECT questionnaire 3 and the Self‐Report Leeds Assessment of Neuropathic Symptoms and Signs (S‐LANSS) scale 4 were developed to help with the diagnosis of neuropathic pain. PainDETECT classifies subjects into groups based on a summative score for 9 items: neuropathic pain component is unlikely (score ≤12), result is ambiguous (score 13–18), and neuropathic pain component is likely (score ≥19).…”

Section: Introductionmentioning

confidence: 99%

“…It uses a summative score for 7 items to classify subjects into 2 groups: pain is not of a predominantly neuropathic origin (score <12) and pain is of a predominantly neuropathic origin (score ≥12). S‐LANSS exhibited good sensitivity (74%) and specificity (76%) when compared with clinical assessment of pain type across groups of individuals with primarily nociceptive conditions (e.g., headaches) or neuropathic conditions (e.g., nerve entrapment) 4. Hochman et al 5 compared a modified painDETECT questionnaire with the S‐LANSS scale in patients with knee OA and observed a strong positive correlation (ρ = 0.73, P < 0.0001).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Pain Phenotype in Patients With Knee Osteoarthritis: Classification and Measurement Properties of painDETECT and Self‐Report Leeds Assessment of Neuropathic Symptoms and Signs Scale in a Cross‐Sectional Study

Moreton

Tew

Nair

et al. 2015

Arthritis Care & Research

107

View full text Add to dashboard Cite

ObjectiveMultiple mechanisms are involved in pain associated with osteoarthritis (OA). The painDETECT and Self‐Report Leeds Assessment of Neuropathic Symptoms and Signs (S‐LANSS) questionnaires screen for neuropathic pain and may also identify individuals with musculoskeletal pain who exhibit abnormal central pain processing. The aim of this cross‐sectional study was to evaluate painDETECT and S‐LANSS for classification agreement and fit to the Rasch model, and to explore their relationship to pain severity and pain mechanisms in OA.MethodsA total of 192 patients with knee OA completed questionnaires covering different aspects of pain. Another group of 77 patients with knee OA completed questionnaires and underwent quantitative sensory testing for pressure–pain thresholds (PPTs). Agreement between painDETECT and S‐LANSS was evaluated using kappa coefficients and receiver operator characteristic (ROC) curves. Rasch analysis of both questionnaires was conducted. Relationships between screening questionnaires and measures of pain severity or PPTs were calculated using correlations.ResultsPainDETECT and S‐LANSS shared a stronger correlation with each other than with measures of pain severity. ROC curves identified optimal cutoff scores for painDETECT and S‐LANSS to maximize agreement, but the kappa coefficient was low (κ = 0.33–0.46). Rasch analysis supported the measurement properties of painDETECT but not those of S‐LANSS. Higher painDETECT scores were associated with widespread reductions in PPTs.ConclusionThe data suggest that painDETECT assesses pain quality associated with augmented central pain processing in patients with OA. Although developed as a screening questionnaire, painDETECT may also function as a measure of characteristics that indicate augmented central pain processing. Agreement between painDETECT and S‐LANSS for pain classification was low, and it is currently unknown which tool may best predict treatment outcome.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Pain Phenotype in Patients With Knee Osteoarthritis: Classification and Measurement Properties of painDETECT and Self‐Report Leeds Assessment of Neuropathic Symptoms and Signs Scale in a Cross‐Sectional Study

Moreton

Tew

Nair

et al. 2015

Arthritis Care & Research

107

View full text Add to dashboard Cite

show abstract

“…Tools used to screen for the presence of neuropathic pain have been developed in English, French and German for use in European countries and the USA, and include the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) [2], the self-reported version of the LANSS (S-LANSS) [3], the Neuropathic Pain Questionnaire (NPQ) [4], the Douleur Neuropathique 4 questions (DN4) [5], painDETECT [6], ID-Pain [7] and the Standardized Evaluation of Pain (StEP) [8]. These tools rely on the patient’s verbal description of the nature of their pain and may include a simple clinical examination.…”

Section: Introductionmentioning

confidence: 99%

“…A score of 12 or more out of 24 is used as a cut-point to identify pain that is predominantly neuropathic in origin. The S-LANSS was designed to remove the need for clinical examination by a health care professional by modifying the two clinical examination items so that they could be undertaken by the patient themselves [3]. Thus, the S-LANSS can be sent to the patient by post or completed verbally via telephone conversation [3,9].…”

Section: Introductionmentioning

confidence: 99%

“…The sensitivity and specificity of the S-LANSS is lower than LANSS (i.e. 74% and 76%, respectively) with an ability to identify neuropathic pain in 75% of patients with clinically confirmed diagnosis of neuropathic pain [3]. Specificity and sensitivity remain stable when translated versions of the LANSS and S-LANSS are used in non-English speaking populations including Turkish [10,11], Spanish [12] and Chinese [13].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya

Garoushi

Johnson

Tashani

2017

Libyan Journal of Medicine

View full text Add to dashboard Cite

In Libya neuropathic pain is rarely assessed in patients with diabetes. The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale is used worldwide to screen for neuropathic pain. There is no Arabic version of LANSS for use in Libya. The aim of this study was to develop an Arabic version of LANSS and to assess its validity and reliability in diabetic patients in Benghazi, Libya. LANSS was translated into Arabic by four bilingual translators and back translated to English by a university academic. Validity and reliability of the Arabic LANSS was assessed on 110 patients attending a Diabetes Centre in Benghazi. Concurrent validity was tested and compared with the Self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS). Test-retest reliability was conducted 1–2 weeks later. Internal consistency and inter-class correlation (ICC) between LANSS and S-LANSS was also tested. Internal consistency within first completion of the Arabic LANSS was acceptable (Cronbach’s alpha = 0.793) and similar to the Arabic S-LANSS (0.796) and the second completion of the Arabic LANSS (0.795). ICC between the Arabic LANSS and the Arabic S-LANSS was 0.999 (p < 0.001). Test-retest reliability (ICC) between first and second completions of the Arabic LANSS was 0.999 (p < 0.001). Kappa measurement of agreement between the two Arabic LANSS completions and S-LANSS was high on all seven items (Kappa >0.95, p < 0.0001). We concluded that the Arabic version of LANSS pain scale was valid and reliable for use on Libyan diabetic patients. This study provided results suggesting that the S-LANSS could also be used on diabetic patients.

show abstract

Developing a Nurse‐Led Clinic for the Treatment of Neuropathic Pain

Mann

2010

Advancing Nursing Practice in Pain Management

View full text Add to dashboard Cite

The S-LANSS score for identifying pain of predominantly neuropathic origin: Validation for use in clinical and postal research

Cited by 532 publications

References 19 publications

Pain Phenotype in Patients With Knee Osteoarthritis: Classification and Measurement Properties of painDETECT and Self‐Report Leeds Assessment of Neuropathic Symptoms and Signs Scale in a Cross‐Sectional Study

Pain Phenotype in Patients With Knee Osteoarthritis: Classification and Measurement Properties of painDETECT and Self‐Report Leeds Assessment of Neuropathic Symptoms and Signs Scale in a Cross‐Sectional Study

Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya

Developing a Nurse‐Led Clinic for the Treatment of Neuropathic Pain

Contact Info

Product

Resources

About